PrairieView Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3K Hold
70
﹤0.01% 324
2025
Q1
$3K Hold
70
﹤0.01% 318
2024
Q4
$3K Hold
70
﹤0.01% 324
2024
Q3
$4K Hold
70
﹤0.01% 312
2024
Q2
$2K Hold
70
﹤0.01% 340
2024
Q1
$5K Hold
70
﹤0.01% 307
2023
Q4
$5K Sell
70
-550
-89% -$36K ﹤0.01% 300
2023
Q3
$42K Hold
620
0.01% 189
2023
Q2
$58K Buy
620
+550
+786% +$42.9K 0.01% 188
2023
Q1
$4K Hold
70
﹤0.01% 348
2022
Q4
$3K Hold
70
﹤0.01% 396
2022
Q3
$2K Hold
70
﹤0.01% 392
2022
Q2
$3K Hold
70
﹤0.01% 394
2022
Q1
$5K Hold
70
﹤0.01% 363
2021
Q4
$5K Buy
+70
New +$6.18K ﹤0.01% 350

Other funds holding EXAS

PrairieView Partners's EXAS Position: Q2 2025 in Review

PrairieView Partners held its Exact Sciences (EXAS) position steady in Q2 2025 at 70 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

PrairieView Partners first reported a position in EXAS in Q4 2021 and has held it in 15 quarters since. The position peaked at $58K in Q2 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • PrairieView Partners held 70 shares of Exact Sciences worth $3K as of Q2 2025.
  • PrairieView Partners left its Exact Sciences share count unchanged in Q2 2025.
  • Exact Sciences made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #324 holding.
  • PrairieView Partners first reported a position in Exact Sciences in Q4 2021 and has held it in 15 quarters since.
  • PrairieView Partners's Exact Sciences position peaked at $58K in Q2 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.